These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 8173175)
1. [Role of TGF beta 1 in the stromal reaction to human colonic tumors]. Garrigue L; Lieubeau B; Barbieux I; Meflah K; Grégoire M Bull Cancer; 1993 Mar; 80(3):225-34. PubMed ID: 8173175 [TBL] [Abstract][Full Text] [Related]
2. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones. Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201 [TBL] [Abstract][Full Text] [Related]
3. The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development. Lieubeau B; Garrigue L; Barbieux I; Meflah K; Gregoire M Cancer Res; 1994 Dec; 54(24):6526-32. PubMed ID: 7987852 [TBL] [Abstract][Full Text] [Related]
4. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724 [TBL] [Abstract][Full Text] [Related]
5. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906 [TBL] [Abstract][Full Text] [Related]
6. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532 [TBL] [Abstract][Full Text] [Related]
7. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Rønnov-Jessen L; Petersen OW Lab Invest; 1993 Jun; 68(6):696-707. PubMed ID: 8515656 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3). Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346 [TBL] [Abstract][Full Text] [Related]
9. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Peehl DM; Sellers RG Exp Cell Res; 1997 May; 232(2):208-15. PubMed ID: 9168795 [TBL] [Abstract][Full Text] [Related]
10. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Kottler UB; Jünemann AG; Aigner T; Zenkel M; Rummelt C; Schlötzer-Schrehardt U Exp Eye Res; 2005 Jan; 80(1):121-34. PubMed ID: 15652533 [TBL] [Abstract][Full Text] [Related]
12. Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding. De Wever O; Westbroek W; Verloes A; Bloemen N; Bracke M; Gespach C; Bruyneel E; Mareel M J Cell Sci; 2004 Sep; 117(Pt 20):4691-703. PubMed ID: 15331629 [TBL] [Abstract][Full Text] [Related]
13. Indirect mitogenic effect of transforming growth factor-beta on cell proliferation of subconjunctival fibroblasts. Kay EP; Lee HK; Park KS; Lee SC Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):481-6. PubMed ID: 9501857 [TBL] [Abstract][Full Text] [Related]
14. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Hasina R; Matsumoto K; Matsumoto-Taniura N; Kato I; Sakuda M; Nakamura T Br J Cancer; 1999 Aug; 80(11):1708-17. PubMed ID: 10468286 [TBL] [Abstract][Full Text] [Related]
15. Clonal heterogeneity of the sensitivity of human colon carcinoma cell lines to TGE beta isoforms. Zhou GH; Sechrist GL; Brattain MG; Mulder KM J Cell Physiol; 1995 Dec; 165(3):512-20. PubMed ID: 7593230 [TBL] [Abstract][Full Text] [Related]
16. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts. Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582 [TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest. Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591 [TBL] [Abstract][Full Text] [Related]
18. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. Zipfel PA; Ziober BL; Morris SL; Mulder KM Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464 [TBL] [Abstract][Full Text] [Related]
20. Interaction between stromal fibroblasts and colorectal cancer cells in the expression of vascular endothelial growth factor. Koshida Y; Kuranami M; Watanabe M J Surg Res; 2006 Aug; 134(2):270-7. PubMed ID: 16600304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]